BEUDAMED
    25 results · 52ms · Sources: EU EUDAMED, US FDA
    Filters FDA Classification ×

    Assay, Proliferation, In Vitro, T Lymphocyte

    FDA classification
    FDA Class 2 ·Assay, Proliferation, In Vitro, T Lymphocyte

    System, Digital Image Communications, Radiological

    FDA classification
    FDA Class 1 ·System, Digital Image Communications, Radiological

    Ldt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd

    FDA classification
    FDA Not Classified ·Ldt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd

    Ivd Offered As Ldt, First Marketed Before May 6, 2024, Not Modified Beyond Scope Described In Preamble To Ldt Final Rule

    FDA classification
    FDA Not Classified ·Ivd Offered As Ldt, First Marketed Before May 6, 2024, Not Modified Beyond Scope Described In Preamble To Ldt Final Rule

    Ivd Offered As Ldt, Not An Ldt Or Under A Targeted Enforcement Discretion Policy Described In Preamble To Ldt Final Rule

    FDA classification
    FDA Not Classified ·Ivd Offered As Ldt, Not An Ldt Or Under A Targeted Enforcement Discretion Policy Described In Preamble To Ldt Final Rule